Medannex

About:

Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.

Website: https://www.medannex.org/

Twitter/X: MedannexLtd

Top Investors: Innovate UK, Morningside Venture Investments, Scottish Investment Bank

Description:

Medannex's goal is to create a first-in-class antibody therapy to improve the lives of people impacted by cancers and autoimmune diseases.

Total Funding Amount:

11.3M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2009-01-01

Founders:

Chris Wood

Number of Employees:

11-50

Last Funding Date:

2024-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai